Healx and Boston Children’s Hospital link up for Barth syndrome drug discovery
UK group Healx is to collaborate with Boston Children’s Hospital and Barth Syndrome Foundation for Barth syndrome.
Read More
Tag: fatal arrhythmias
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
